Clinical trial
Pharmacologic Attenuation of Ketamine Using Nitroprusside
NCT03102736 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacologic Attenuation of Ketamine Using Nitroprusside
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 14, 2017
- Completion date
- June 12, 2019
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression